|
TO STUDY THE MAJOUR FACTORS INFLUENCE THE PRESCRIPTION PATTERN OF DOCTORS
1
Author(s):
SUPRIT JOHN JOSHI
Vol - 5, Issue- 8 ,
Page(s) : 48 - 53
(2014 )
DOI : https://doi.org/10.32804/IRJMST
Abstract
Introduction
The pharmaceutical industry is the world’s largest industry due to worldwide revenues of approximately US$2.8 trillion. Pharma industry has seen major changes in the recent years that place new demands on payers, providers and manufacturers. Customers now demand the same choice and convenience from pharma industry that they find in other segment. Indian Pharmaceutical Industry is poised for high consistent growth over the next few years, driven by a multitude of factors. Top Indian Companies like Ranbaxy, GSK, CIPLA and Dabur have already established their presence. The pharmaceutical industry is a knowledge driven industry and is heavily dependent on Research and Development for new products and growth. However, basic research (discovering new molecules) is a time consuming and expensive process and is thus, dominated by large global multinationals.
- Baethge C (2008). Transparent texts. Dtsch Arztebl Int., 105(40): 675-9.
- Bloor K, Freemantle N (1996). Lessons from international experience in controlling pharmaceutical expenditure II: Influencing doctors. BMJ, 312: 1525-1527.
- Bowman MA, Pearle DL (1988). Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J. Contin. Edu. Health Prof., 8: 13-20.
- Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D (2007). A national survey of physician-industry relationships. N. Eng. J. Med., 356: 1742-1750.
- Chimonas S, Brennan TA, Rothman DJ (2007). Physicians and drug representatives: exploring the dynamics of the relationship. J. Gen. Int. Med., 22: 184-190.
- Chren MM, Landefeld CS (1994). Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA, 271: 684-689.
- Denig P, Haajer-Ruskamp FM, Zijsling Hox DH (1998). Physicians choose drugs. Soc. Sci. Med., 7: 1381-1386.
- Fischer MA, Keough ME, Baril JL, Saccoccio L, Mazor KM (2009). Prescribers and pharmaceutical representatives: why are we still meeting? J. Gen. Int. Med., 24: 795-801.
- Gagnon MA, Lexchin J (2008). The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med., 5: e1. doi:10.1371/journal.pmed.0050001.
|